GlaxoSmithKline PLC Total Voting Rights (0478E)
01 Julio 2019 - 06:08AM
UK Regulatory
TIDMGSK
RNS Number : 0478E
GlaxoSmithKline PLC
01 July 2019
GlaxoSmithKline plc
Total Voting Rights and Capital
In conformity with the Financial Conduct Authority's Disclosure
Guidance and Transparency Rule 5.6.1R, GlaxoSmithKline plc (the
'Company') hereby notifies the market of the following:
The Company's issued share capital as at 28 June 2019 consisted
of 5,381,658,150 shares of 25 pence each ('Ordinary Shares'), of
which 393,505,950 Ordinary Shares were held in Treasury.
Therefore, the total number of voting rights in the Company is
4,988,152,200. This figure may be used by shareholders as the
denominator for the calculations by which they will determine if
they are required to notify their interest in, or a change to their
interest in, the Company under the Financial Conduct Authority's
Disclosure Guidance and Transparency Rules.
V A Whyte
Company Secretary
1 July 2019
This information is provided by RNS, the news service of the
London Stock Exchange. RNS is approved by the Financial Conduct
Authority to act as a Primary Information Provider in the United
Kingdom. Terms and conditions relating to the use and distribution
of this information may apply. For further information, please
contact rns@lseg.com or visit www.rns.com.
END
TVRUGUQUMUPBGGG
(END) Dow Jones Newswires
July 01, 2019 07:08 ET (11:08 GMT)
Gsk (LSE:GSK)
Gráfica de Acción Histórica
De Feb 2024 a Mar 2024
Gsk (LSE:GSK)
Gráfica de Acción Histórica
De Mar 2023 a Mar 2024